rimtuzalcap   Click here for help

GtoPdb Ligand ID: 12649

Synonyms: CAD-1883 | CAD1883 | compound 1 [US9975886B1]
Compound class: Synthetic organic
Comment: Rimtuzalcap (CAD-1883) is a KCa2 channel activator (positive allosteric modulator) [1], that was developed for potential to treat movement disorders such as essential tremor and spinocerebellar ataxia.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 64.82
Molecular weight 378.42
XLogP 2.43
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=NN(C=C1)C2=NC(=CC(=N2)NC3CCC(CC3)(F)F)N4CCOCC4
Isomeric SMILES CC1=NN(C=C1)C2=NC(=CC(=N2)N3CCOCC3)NC4CCC(CC4)(F)F
InChI InChI=1S/C18H24F2N6O/c1-13-4-7-26(24-13)17-22-15(21-14-2-5-18(19,20)6-3-14)12-16(23-17)25-8-10-27-11-9-25/h4,7,12,14H,2-3,5-6,8-11H2,1H3,(H,21,22,23)
InChI Key OVLIDRAJVMUEMC-UHFFFAOYSA-N
References
1. Amrutkar DVm Foster K, Jacobsen TA, Jefson MR, Keaney GF, Larsen JS, Nielsen KS. (2018)
Potassium channel modulators.
Patent number: US9975886B1. Assignee: Cadent Therapeutics Inc. Priority date: 23/01/2018. Publication date: 22/04/2018.